CHRISTOPHER KERSTING: Open Payments
NPI 1972169746 · BLUE ASH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 7 payments from 6 companies in 2025. Trend: 2023 $752 · 2024 $825 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $148 |
| Gilead Sciences, Inc. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Novo Nordisk Inc | 1 | $121 |
| Lilly USA, LLC | 1 | $117 |
| Neurelis, Inc. | 2 | $83 |
Products named: REPATHA, Yeztugo, Auvelity, Wegovy, ZEPBOUND, VALTOCO.
Industry payments across OH — which companies pay providers there.
